维普中文期刊产品整合服务
53篇 您的检索式:作者名="OGISO Y"
    题名 作者 年代 出处 被引量
1Proteasome inhibition circumvents solid tumor resistance to topoisomerase Ⅱ-directed drugs显示文摘Ogiso Y Tomida A Lei S 2000Cancer Research2000,60,9:1
2Pharmacokinetics of ozagrel and its metabolites after intravenous and oral administrations 显示文摘OGISO T IWAKI M HARA Y 1997Pharm Sci1997,86,10:1
3Trial on the applica- tion of capillary phenomenon of solid CaO to desulfurization of liquid Fe 显示文摘Tanaka T Ogiso Y Ueda M 2010ISIJ Int2010,50,8:1
4Proteasome inhibition circumvents solid tumor resistance to topoisomerase Ⅱ -directed drugs显示文摘Ogiso Y Tomida A Lei S 2000Cancer Res2000,60,6:1
5Proteasome inhibition circumvents solid tumor resistance to topoisomerase Ⅱ-directed drugs显示文摘Ogiso Y Tomida A Lei S 2000Cancer Res2000,60,9:1
6Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase Ⅱ-directed drugs显示文摘Ogiso Y Tomida A Tsuruo T 2002Cancer Ras2002,62,17:1
7Proteasome inhibition circumvents solid tumor resistance to topoisomerase Ⅱ-directed drug显示文摘Ogiso Y Tomida A Lei S 2000Cancer Res2000,60,:1
8Pharmacokinetics of ozagrel and its metabolites after intravenous and oral administrations显示文摘OGISO T IWAKI M HARA Y etal 1997Pharm Sci1997,86,10:1
9Suppression of various human tumor cell lines by a dominant negative H-ras mutant显示文摘Ogiso Y Sakai N watari H 1994Gene Ther1994,1,6:1
10Nuclear localization of proteasomes participates in stress-inducible resistance of solid tumor cells to topoisomerase Ⅱ-directed drugs 显示文摘OGISO Y TOMIDA A TSURUO T 2002Cancer Res2002,62,17:1
11Software obfuscation on a theoretical basis and its implementation显示文摘Ogiso T Sakabe Y 2003IEEE Transactions on Fundamentals2003,86,1:1
12Proteasome inhibition circumvents solid tumor resisitance to topoisomerse Ⅱ-directed drugs 显示文摘Ogiso Y Tomida A Lei S 2000Cancer Res2000,60,9:1
13Software obfuscation on a theoretical basis and its implementation显示文摘OGISO T SAKABE Y 2003I EEE Trans on Fundamentals2003,86,1:1
14Thermodynamic study on enhancement of percutaneous penetration of drugs by azonc 显示文摘Ito Y Ogiso T Iwaki M 1988Pharmacobiodyn1988,11,11:1
15Percutaneous absorption of valproic acid and its plasma concentration after application of ointment 显示文摘Ogiso T Ito Y Iwaki M 1987J Pharmacobiodyn1987,10,10:1
16Proteasome inhibition circumvents solid tumor resistance to topoisomerase Ⅱ-directed drugs显示文摘Ogiso Y Tomida A Lei S 2000Cancer Res2000,60,9:1
17Pharmacokinetics and first-pass effect of bromhexine in rats 显示文摘Iwaki M Ogiso T Ito Y 1990J Pharmacobiodyn1990,13,8:1
18Proteasome inhibition circum- vents solid tumor resistance to topoisomerase II - directed drugs 显示文摘Ogiso Y Tomida A Lei S 2000Cancer Research2000,60,9:1
19Proteasome inhibition circumvents solid tumor resistance to topoisomerase II -directed drugs显示文摘Ogiso Y Tomida A Lei S 2000Cancer Res2000,60,9:1
20Formation and progres- sion of cavitation erosion surface for long exposure 显示文摘Hattori S J Ogiso T K Minami Y S 2008Wear2008,265,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费